ATNF
Price
$3.00
Change
+$0.87 (+40.85%)
Updated
Jul 25 closing price
Capitalization
18.12M
ENTBF
Price
$0.09
Change
+$0.02 (+28.57%)
Updated
Jul 24 closing price
Capitalization
1.02M
Interact to see
Advertisement

ATNF vs ENTBF

Header iconATNF vs ENTBF Comparison
Open Charts ATNF vs ENTBFBanner chart's image
180 Life Sciences
Price$3.00
Change+$0.87 (+40.85%)
Volume$16.55M
Capitalization18.12M
ENTHEON BIOMEDICAL
Price$0.09
Change+$0.02 (+28.57%)
Volume$531
Capitalization1.02M
ATNF vs ENTBF Comparison Chart in %
Loading...
ATNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ENTBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATNF vs. ENTBF commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATNF is a StrongBuy and ENTBF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (ATNF: $3.00 vs. ENTBF: $0.09)
Brand notoriety: ATNF and ENTBF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATNF: 638% vs. ENTBF: 60%
Market capitalization -- ATNF: $18.12M vs. ENTBF: $1.02M
ATNF [@Biotechnology] is valued at $18.12M. ENTBF’s [@Biotechnology] market capitalization is $1.02M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATNF’s FA Score shows that 0 FA rating(s) are green whileENTBF’s FA Score has 0 green FA rating(s).

  • ATNF’s FA Score: 0 green, 5 red.
  • ENTBF’s FA Score: 0 green, 5 red.
According to our system of comparison, ENTBF is a better buy in the long-term than ATNF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATNF’s TA Score shows that 5 TA indicator(s) are bullish while ENTBF’s TA Score has 4 bullish TA indicator(s).

  • ATNF’s TA Score: 5 bullish, 5 bearish.
  • ENTBF’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both ATNF and ENTBF are a good buy in the short-term.

Price Growth

ATNF (@Biotechnology) experienced а +59.57% price change this week, while ENTBF (@Biotechnology) price change was +2.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.62%. For the same industry, the average monthly price growth was +17.39%, and the average quarterly price growth was +28.36%.

Reported Earning Dates

ATNF is expected to report earnings on May 15, 2025.

Industries' Descriptions

@Biotechnology (+7.62% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATNF($18.1M) has a higher market cap than ENTBF($1.02M). ATNF YTD gains are higher at: 64.835 vs. ENTBF (-36.663). ENTBF has higher annual earnings (EBITDA): -403.94K vs. ATNF (-7.69M). ATNF has more cash in the bank: 3.73M vs. ENTBF (525K). ATNF (0) and ENTBF (0) have equivalent revenues.
ATNFENTBFATNF / ENTBF
Capitalization18.1M1.02M1,776%
EBITDA-7.69M-403.94K1,904%
Gain YTD64.835-36.663-177%
P/E Ratio0.13N/A-
Revenue00-
Total Cash3.73M525K710%
Total Debt152KN/A-
FUNDAMENTALS RATINGS
ATNF: Fundamental Ratings
ATNF
OUTLOOK RATING
1..100
35
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATNFENTBF
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 9 days ago
87%
N/A
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ATNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ENTBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EME635.0656.26
+9.72%
EMCOR Group
ALVO9.610.45
+4.91%
Alvotech
NXRT33.850.04
+0.12%
NexPoint Residential Trust
BZUN2.80-0.02
-0.71%
Baozun
ICU0.77-0.01
-1.04%
SeaStar Medical Holding Corp

ATNF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATNF has been loosely correlated with PRQR. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ATNF jumps, then PRQR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATNF
1D Price
Change %
ATNF100%
+40.85%
PRQR - ATNF
54%
Loosely correlated
-1.33%
KRRO - ATNF
44%
Loosely correlated
+0.69%
WVE - ATNF
43%
Loosely correlated
+0.12%
JSPR - ATNF
41%
Loosely correlated
+0.64%
BDRX - ATNF
39%
Loosely correlated
-0.28%
More

ENTBF and

Correlation & Price change

A.I.dvisor tells us that ENTBF and OVID have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ENTBF and OVID's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENTBF
1D Price
Change %
ENTBF100%
N/A
OVID - ENTBF
23%
Poorly correlated
-10.75%
IMRN - ENTBF
22%
Poorly correlated
-1.15%
ATNF - ENTBF
21%
Poorly correlated
+40.85%
CYBN - ENTBF
12%
Poorly correlated
-0.62%
HLOSF - ENTBF
7%
Poorly correlated
N/A
More